Medi Caps Ltd
₹ 51.9
4.38%
22 Nov
- close price
About
Incorporated in 1983, Medi-Caps Limited flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. The company together with its subsidiary & now as real estate manages the marketing, production and distribution of products. [1]
Key Points
- Market Cap ₹ 64.7 Cr.
- Current Price ₹ 51.9
- High / Low ₹ 63.5 / 40.6
- Stock P/E 26.3
- Book Value ₹ 54.2
- Dividend Yield 0.00 %
- ROCE 7.34 %
- ROE 5.91 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.96 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.49% over last 3 years.
- Company has high debtors of 237 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.03 | 27.37 | 27.37 | 25.04 | 22.76 | 26.38 | 25.28 | 10.91 | 0.00 | 0.00 | 0.10 | 7.17 | 6.29 | |
| 22.24 | 24.21 | 25.52 | 23.42 | 21.99 | 25.93 | 25.32 | 19.97 | 0.00 | 0.56 | 0.39 | 2.33 | 3.08 | |
| Operating Profit | 3.79 | 3.16 | 1.85 | 1.62 | 0.77 | 0.45 | -0.04 | -9.06 | 0.00 | -0.56 | -0.29 | 4.84 | 3.21 |
| OPM % | 14.56% | 11.55% | 6.76% | 6.47% | 3.38% | 1.71% | -0.16% | -83.04% | -290.00% | 67.50% | 51.03% | ||
| -1.33 | -1.57 | 1.21 | 0.46 | 1.13 | 0.67 | 1.14 | 1.11 | -0.12 | 0.64 | 0.53 | 0.15 | 0.35 | |
| Interest | 0.01 | 0.03 | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.63 | 0.34 | 0.32 | 0.33 | 0.37 | 0.34 | 0.35 | 0.36 | 0.00 | 0.09 | 0.09 | 0.16 | 0.16 |
| Profit before tax | 1.82 | 1.22 | 2.73 | 1.74 | 1.51 | 0.76 | 0.71 | -8.32 | -0.12 | -0.02 | 0.15 | 4.83 | 3.40 |
| Tax % | 63.19% | 89.34% | 29.30% | 32.18% | 23.18% | 26.32% | 16.90% | 0.12% | -8.33% | 50.00% | 0.00% | 19.46% | |
| 0.67 | 0.14 | 1.94 | 1.18 | 1.16 | 0.56 | 0.59 | -8.33 | -0.11 | -0.04 | 0.15 | 3.89 | 2.46 | |
| EPS in Rs | 0.54 | 0.11 | 1.56 | 0.95 | 0.93 | 0.45 | 0.47 | -6.68 | -0.09 | -0.03 | 0.12 | 3.12 | 1.98 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -22% |
| 3 Years: | % |
| TTM: | 183% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 39% |
| 5 Years: | 57% |
| 3 Years: | 622% |
| TTM: | 73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 34% |
| 3 Years: | 6% |
| 1 Year: | 15% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -2% |
| 3 Years: | 1% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves | 49.81 | 49.95 | 51.89 | 53.07 | 53.90 | 54.45 | 55.04 | 47.38 | 48.50 | 48.82 | 48.64 | 54.02 | 55.07 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.12 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 4.12 | 4.93 | 4.58 | 5.47 | 5.64 | 4.73 | 6.16 | 1.65 | 1.66 | 0.52 | 0.52 | 1.60 | 0.68 | |
| Total Liabilities | 66.40 | 67.35 | 68.94 | 71.01 | 72.01 | 71.82 | 73.79 | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.22 |
| 4.28 | 3.90 | 3.96 | 3.64 | 4.96 | 5.01 | 4.99 | 3.63 | 3.26 | 2.78 | 2.46 | 2.26 | 2.18 | |
| CWIP | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 33.75 | 41.75 | 48.25 | 49.56 | 49.29 | 49.81 | 50.67 | 52.15 | 54.39 | 53.68 | 51.98 | 55.11 | 56.85 |
| 28.37 | 21.60 | 16.73 | 17.81 | 17.76 | 17.00 | 18.13 | 5.78 | 4.98 | 5.35 | 7.19 | 10.72 | 9.19 | |
| Total Assets | 66.40 | 67.35 | 68.94 | 71.01 | 72.01 | 71.82 | 73.79 | 61.56 | 62.63 | 61.81 | 61.63 | 68.09 | 68.22 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.99 | -1.57 | 6.88 | 1.44 | 2.70 | 0.86 | 1.33 | -0.92 | 2.24 | -0.95 | -2.60 | 3.09 | |
| 7.27 | 1.61 | -6.78 | -1.31 | -1.76 | -0.96 | -1.19 | -0.40 | -2.19 | 1.01 | 1.85 | -3.09 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | -0.05 | -0.06 | -0.06 | 0.00 | 0.00 | 0.00 | |
| Net Cash Flow | -0.72 | 0.04 | 0.10 | 0.13 | 0.94 | 0.07 | 0.09 | -1.38 | -0.02 | 0.06 | -0.75 | 0.00 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94.65 | 106.69 | 88.55 | 96.35 | 97.18 | 96.02 | 90.24 | 88.99 | 8,176.00 | 236.72 | ||
| Inventory Days | 156.54 | 169.28 | 194.04 | 248.47 | 281.91 | 219.00 | 266.47 | 20.89 | 1,825.00 | |||
| Days Payable | 20.09 | 36.41 | 33.53 | 60.03 | 83.09 | 55.89 | 118.09 | 16.56 | 1,095.00 | |||
| Cash Conversion Cycle | 231.10 | 239.55 | 249.06 | 284.79 | 296.00 | 259.13 | 238.62 | 93.33 | 8,176.00 | 236.72 | ||
| Working Capital Days | 265.30 | 153.09 | 158.96 | 175.94 | 179.45 | 157.59 | 160.12 | 133.82 | 25,623.00 | 481.07 | ||
| ROCE % | 6.18% | 1.94% | 4.29% | 2.69% | 1.52% | 1.14% | 0.77% | -13.56% | 0.00% | -0.85% | -0.62% | 7.34% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Nov - Extract of un-audited standalone and consolidated financial results of the company for the quarter/half year ended 30.09.2024, published in free press English edition and choutha …
- Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2024 12 Nov
-
Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 12TH NOVEMBER, 2024 PURSUANT TO REGULATION 30 OF SEBI (LODR) REGULATIONS, 2015.
12 Nov - Board approved unaudited financial results for Q2 FY2024.
-
Board Meeting Intimation for Intimation For Meeting Of Board (Serial No. 03/2024-25) Of The Company, Scheduled To Be Held On Tuesday, 12Th Day Of November, 2024 Pursuant To Regulation 29 Of SEBI (LODR) Regulations, 2015.
6 Nov - Board meeting scheduled for November 12, 2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
7 Oct - Certificate for compliance of SEBI regulations for Q2 2024.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Products:[1]
The company claims its products to be Sodium Lauryl Sulfate(SLS) free and Preservatives free. There are three main products which the company manufactures -
Empty Hard Gelatin Capsules Shells
The company manufactures these Shells in 6 sizes ranging from 00,0,1el,1,2,3,4 fortified with more than thousand shades.
Halal Gelatin Capsules
The company supplies HALAL GELATIN as there are very less suppliers of genuine Halal quality products.
Liquid Filled Capsules
These manufactured capsules are suitable for pharmaceutical, herbal, nutraceutical, agricultural and especially for cosmetic industry. They can be filled with active substances in form of liquids.